Allogeneic CART-33

CAR-T therapy targeting CD33 (allogeneic) · The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic CART-33, covering 2016-06-15 to 2016-06-15. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic CART-33 for Relapsed/Refractory CD33+ AML [Phase 1]